ArticlePharmaceutics2022

Risk-Assessment-Based Optimization Favours the Development of Albumin Nanoparticles with Proper Characteristics Prior to Drug Loading.

Gábor Katona et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.